Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner

Tenofovir (TFV) is used in combination with other antiretroviral drugs for human immunodeficiency virus (HIV) treatment and prevention. TFV requires two phosphorylation steps to become pharmacologically active; however, the kinases that activate TFV in cells and tissues susceptible to HIV infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Lade, Julie M., To, Elaine E., Hendrix, Craig W., Bumpus, Namandjé N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588390/
https://www.ncbi.nlm.nih.gov/pubmed/26501112
http://dx.doi.org/10.1016/j.ebiom.2015.07.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588390/
https://www.ncbi.nlm.nih.gov/pubmed/26501112
http://dx.doi.org/10.1016/j.ebiom.2015.07.008

Ejemplares similares